Uncategorized
Ocular Therapeutix prices initial public offering at $13 per share
Ocular Therapeutix has priced its initial public offering of 5,000,000 common stock shares at $13 per share, before underwriting discounts and commissions, according to a company press release.The company has also granted the underwriters an option for a 30-day purchase period at the public offering price excluding the underwriting discount — up to 750,000 additional shares of common stock to cover over-allotments, according to the press release.